This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.
PRESS RELEASE from provider: Business Wire
This content is a press release from our partner Business Wire. The AP newsroom and editorial departments were not involved in its creation.

Global Drug-Coated Balloons Market 2019-2024: Market is Driven by the Spreading Awareness, Education, and Support for Several CVDs - ResearchAndMarkets.com

February 22, 2019

DUBLIN--(BUSINESS WIRE)--Feb 22, 2019--The “Drug-Coated Balloons Market - Global Outlook and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering.

The global drug-coated balloons market is expected to reach revenues of more than $1 billion by 2024, growing at a CAGR of around 17% during 2018-2024.

The global drug-coated balloons market is driven by the spreading awareness, education, and support for several CVDs. The DCBs market is one of the fastest growing segments in cardiovascular devices segment in the healthcare industry. The market research report provides in-depth market analysis and segmental analysis of the global drug-coated balloons market by indication, end-users, and geography.

Drug-Coated Balloons Market - Dynamics

There has been an increasing usage of Drug-coated balloons over the standard PTA Balloons for treating peripheral and coronary arterial diseases. The rapid growth and need for significant improvement in MI procedures and MI surgical techniques have led to this technical improvement in the balloon catheter segment.

This significant development and launch of several drug-coated balloons have enhanced the safety, effectiveness and clinical outcomes of angioplasty procedures.A lot of vendors have a rich pipeline of devices for arterial, AVF, and AVG indications.

Significant players in the market have their own in-house R&D activities to develop and commercialize DCB’s. They have promising investigational DCBs under development and most of the small players are also actively involved in the development of novel and advanced drug-coated balloon devices.

The vendors are conducting clinical trials to ensure the safety and for seeking regulatory approval from the USFDA in the coming years previously drug-coated balloons were only used for treating SFA in patients with PAD. Due to improvements in technological innovations, and increased clinical trials the application of this is expanded and used to treat other endovascular diseases. These days PAD patients with BTK artery lesions, small vessel disease, complex CAD, AVG, and AVF are also treated with advanced drug-coated balloon’s. In recent years, the regulatory bodies gave expanded indication approvals for the existing commercial drug-coated balloons.

Key Vendor Analysis

The global drug-coated balloons market is highly dynamic due to the presence of international, regional, and local players. The top companies are focusing on wide geographical reach, diversified product portfolio, and a strong focus on innovation and research activities to attract a maximum of consumers in the global market.

The emerging companies to expand their presence, enhance product portfolio, and improve expertise to sustain the competition in the market. The increase in M&A activities will drive consolidation in the global drug-coated balloons market.

The major vendors in the global market are:

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Report Coverage

4.1 Market Definition

4.2 Base Year

4.3 Scope of Study

4.3.1 Market Segmentation by Indication Type

4.3.2 Market Segmentation by End-user Type

4.3.3 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Inclusions

5.3 Exclusions

5.4 Currency Conversion

5.5 Market Derivation

6 Market at a Glance

7 Introduction

7.1 DCBs: An Overview

7.2 Market Snapshot

8 Market Dynamics

8.1 Market Growth Enablers

8.1.1 Availability of Abundant Clinical Data and Increased Focus on Clinical Trials

8.1.2 New Product Approvals

8.1.3 Increase in Prevalence of Cardiovascular Diseases

8.1.4 Growing Demand for DCBs to Lower Restenosis and Revascularization Rates

8.2 Market Growth Restraints

8.2.1 Threats from Substitutes

8.2.2 Regulatory Challenges for Vendors

8.2.3 Hurdles in Reimbursement Coverage

8.3 Market Opportunities & Trends

8.3.1 Availability of Latest Generation DCBs

8.3.2 Robust DCB Devices in Pipeline

8.3.3 Expanded Indication Approvals of Existing DCBs

8.3.4 Emergence of Sirolimus-coated Balloon Catheters

9 Global Drug-coated Balloons Market

9.1 Market Overview

9.2 Market Size & Forecast

9.3 Porter’s Five Forces Analysis

9.3.1 Threat of New Entrants

9.3.2 Bargaining Power of Suppliers

9.3.3 Bargaining Power of Buyers

9.3.4 Threat of Substitutes

9.3.5 Competitive Rivalry

10 By Indication

10.1 Market Overview

10.2 DCBs for PAD

10.3 DCBs for CAD

10.4 DCBs for Other Indications

11 By End-users

11.1 Market Overview

11.2 Hospitals

11.3 Cardiac Catheterization Labs

11.4 ASCs

12 By Geography

12.1 Market Overview

13 North America

14 Europe


16 Rest of the World

17 Competitive Landscape

17.1 Competitive Scenario

17.2 Market Vendor Share/Ranking Analysis

18 Key Company Profiles

18.1 Medtronic

18.2 BD

18.3 Koninklijke Philips

18.4 B. Braun Melsungen

19 Key Companies to Watch


19.2 Boston Scientific

19.3 Opto Circuits (India)

20 Other Prominent Vendors

20.1 Acotec Scientific

20.2 AR Baltic Medical

20.3 Acrostak

20.4 Biosensors International Group

20.5 Cardionovum

20.6 Concept Medical


20.8 Hexacath

20.9 iVascular SLU

20.10 M.A. Med Alliance

20.11 Minvasys

20.12 Orchestra BioMed

20.13 QT Vascular

20.14 RD Global-Invamed

20.15 Surmodics

20.16 Terumo

20.17 Wellinq

For more information about this report visit https://www.researchandmarkets.com/research/x6nk3d/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190222005151/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Drug Delivery,Cardiovascular Devices



SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/22/2019 05:08 AM/DISC: 02/22/2019 05:08 AM